Human Gene TECR (ENST00000215567.10_4) from GENCODE V47lift37
Description: trans-2,3-enoyl-CoA reductase, transcript variant 1 (from RefSeq NM_138501.6)
Gencode Transcript: ENST00000215567.10_4
Gencode Gene: ENSG00000099797.15_9
Transcript (Including UTRs)
Position: hg19 chr19:14,640,406-14,676,792 Size: 36,387 Total Exon Count: 13 Strand: +
Coding Region
Position: hg19 chr19:14,640,509-14,676,683 Size: 36,175 Coding Exon Count: 13
Data last updated at UCSC: 2024-08-22 23:36:26
Sequence and Links to Tools and Databases
Comments and Description Text from UniProtKB
ID: TECR_HUMAN
DESCRIPTION: RecName: Full=Very-long-chain enoyl-CoA reductase; EC=1.3.1.93; AltName: Full=Synaptic glycoprotein SC2; AltName: Full=Trans-2,3-enoyl-CoA reductase; Short=TER;
FUNCTION: Reduces trans-2,3-stearoyl-CoA to stearoyl-CoA of long and very long chain fatty acids.CATALYTIC ACTIVITY: A very-long-chain acyl-CoA + NADP(+) = a very- long-chain trans-2,3-dehydroacyl-CoA + NADPH.SUBUNIT: Interacts with ELOVL1 and LASS2.SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein.TISSUE SPECIFICITY: Expressed in most tissues tested. Highly expressed in skeletal muscle.DISEASE: Defects in TECR are the cause of mental retardation autosomal recessive type 14 (MRT14) [MIM:614020] . Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period.SIMILARITY: Belongs to the steroid 5-alpha reductase family.
Primer design for this transcript
MalaCards Disease Associations
Comparative Toxicogenomics Database (CTD)
The following chemicals interact with this gene
Common Gene Haplotype Alleles
Press "+" in the title bar above to open this section.
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
Microarray Expression Data
Press "+" in the title bar above to open this section.
mRNA Secondary Structure of 3' and 5' UTRs
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
Protein Domain and Structure Information
InterPro Domains: Graphical view of domain structure IPR001104 - 3-oxo-5_a-steroid_4-DH_C
Pfam Domains: PF02544 - 3-oxo-5-alpha-steroid 4-dehydrogenase
SCOP Domains: 54236 - Ubiquitin-like
55120 - Pseudouridine synthase
Protein Data Bank (PDB) 3-D Structure
ModBase Predicted Comparative 3D Structure on Q9NZ01
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Descriptions from all associated GenBank mRNAs
HZ043268 - JP 2015510401-A/358: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.HZ081894 - JP 2015514392-A/358: MicroRNAS FOR THE GENERATION OF ASTROCYTES.HZ408717 - JP 2015528002-A/1314: CHIRAL CONTROL.LF404365 - JP 2015509366-A/358: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.LG052051 - KR 1020150036642-A/1317: CHIRAL CONTROL.MA353896 - JP 2018075017-A/358: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.LF384407 - JP 2014500723-A/191910: Polycomb-Associated Non-Coding RNAs.BC005384 - Homo sapiens glycoprotein, synaptic 2, mRNA (cDNA clone IMAGE:3935809), partial cds.AK299134 - Homo sapiens cDNA FLJ58248 complete cds, highly similar to Synaptic glycoprotein SC2.AK094087 - Homo sapiens cDNA FLJ36768 fis, clone ADIPS1000064, highly similar to Synaptic glycoprotein SC2.DL491631 - Novel nucleic acids.FW312399 - DETECTING NUCLEIC ACIDS.FW364551 - Oligonucleotides for modulating target RNA activity.HI964829 - Sequence 114 from Patent WO2010139812.HI966431 - Sequence 751 from Patent WO2010139811.HI967297 - Sequence 751 from Patent WO2010139810.HV335388 - JP 2011097833-A/8: Using frequency of methylations of specific genes as head and neck tumor biomarker.HV595463 - JP 2010539959-A/844: Micromirs.HW612915 - WO 2014126233-A/5: Method for measuring miRNA, and therapeutic agent for cancer and pharmaceutical composition for cancer therapy containing the same.HW669849 - JP 2013537538-A/580: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.HZ043156 - JP 2015510401-A/246: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF.HZ074505 - JP 2013535982-A/596: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.HZ081782 - JP 2015514392-A/246: MicroRNAS FOR THE GENERATION OF ASTROCYTES.HZ158020 - JP 2015130862-A/844: Micromirs.HZ186864 - JP 2015146814-A/613: Oligonucleotides for modulating target RNA activity.HZ482476 - JP 2015535430-A/2982: TERMINALLY MODIFIED RNA.HZ792407 - JP 2016504050-A/4152: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.JA400867 - Sequence 114 from Patent WO2011080318.JA401845 - Sequence 114 from Patent WO2011080315.JA402852 - Sequence 114 from Patent WO2011080316.JA405483 - Sequence 114 from Patent EP2336353.JA427229 - Sequence 562 from Patent WO2011072177.JA429009 - Sequence 114 from Patent WO2011095623.JA660783 - Sequence 237 from Patent WO2011131354.JA791637 - Sequence 39 from Patent WO2012089772.JB620690 - Sequence 670 from Patent WO2013063544.JC244594 - Sequence 214 from Patent WO2012020308.JC270189 - Sequence 580 from Patent WO2012020307.JC515139 - Sequence 5392 from Patent WO2014113089.JE978792 - Sequence 237 from Patent EP2865765.LF160946 - JP 2016513950-A/1012: Oligomers with improved off-target profile.LF404253 - JP 2015509366-A/246: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.LP727057 - Sequence 751 from Patent EP2883966.LP819327 - Sequence 751 from Patent EP3296406.LP939269 - Sequence 751 from Patent EP3184651.LQ072727 - Sequence 3051 from Patent EP2964234.LX270646 - JP 2016056210-A/580: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.LY405528 - KR 1020160117535-A/833: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.LZ234221 - JP 2017184756-A/613: Oligonucleotides for modulating target RNA activity.MA260767 - JP 2017505623-A/833: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.MA353784 - JP 2018075017-A/246: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS.MS833968 - Sequence 114 from Patent EP3112479.AK315412 - Homo sapiens cDNA, FLJ96461, Homo sapiens glycoprotein, synaptic 2 (GPSN2), mRNA.AK001416 - Homo sapiens cDNA FLJ10554 fis, clone NT2RP2002385, highly similar to Synaptic glycoprotein SC2.BC007801 - Homo sapiens glycoprotein, synaptic 2, mRNA (cDNA clone MGC:14250 IMAGE:4128702), complete cds.BC013881 - Homo sapiens glycoprotein, synaptic 2, mRNA (cDNA clone MGC:10603 IMAGE:3928698), complete cds.BC005952 - Homo sapiens glycoprotein, synaptic 2, mRNA (cDNA clone MGC:14589 IMAGE:4249841), complete cds.LF373202 - JP 2014500723-A/180705: Polycomb-Associated Non-Coding RNAs.AF038958 - Homo sapiens synaptic glycoprotein SC2 spliced variant mRNA, complete cds.GQ900916 - Homo sapiens clone HEL-T-28 epididymis secretory sperm binding protein mRNA, complete cds.BC034484 - Homo sapiens glycoprotein, synaptic 2, mRNA (cDNA clone IMAGE:4823258).BC002425 - Homo sapiens glycoprotein, synaptic 2, mRNA (cDNA clone MGC:1968 IMAGE:3163592), complete cds.AF222742 - Homo sapiens synaptic glycoprotein SC2 (SC2) mRNA, complete cds.AX771269 - Sequence 3 from Patent WO03027225.AF038959 - Homo sapiens synaptic glycoprotein SC2 mRNA, complete cds.AB529027 - Synthetic construct DNA, clone: pF1KB3393, Homo sapiens GPSN2 gene for trans-2,3-enoyl-CoA reductase, without stop codon, in Flexi system.DQ891949 - Synthetic construct clone IMAGE:100004579; FLH181693.01X; RZPDo839G02136D glycoprotein, synaptic 2 (GPSN2) gene, encodes complete protein.DQ895135 - Synthetic construct Homo sapiens clone IMAGE:100009595; FLH181689.01L; RZPDo839G02135D glycoprotein, synaptic 2 (GPSN2) gene, encodes complete protein.GQ129437 - Synthetic construct Homo sapiens clone HAIB:100068520; DKFZo004G0234 glycoprotein, synaptic 2 protein (GPSN2) gene, partial cds.EU832830 - Synthetic construct Homo sapiens clone HAIB:100067859; DKFZo008G0233 glycoprotein, synaptic 2 protein (GPSN2) gene, encodes complete protein.BC000174 - Homo sapiens, clone IMAGE:2901253, mRNA, partial cds.CU675805 - Synthetic construct Homo sapiens gateway clone IMAGE:100018821 5' read GPSN2 mRNA.CR456892 - Homo sapiens full open reading frame cDNA clone RZPDo834D1211D for gene GPSN2, glycoprotein, synaptic 2; complete cds, incl. stopcodon.BT007179 - Homo sapiens glycoprotein, synaptic 2 mRNA, complete cds.KJ892790 - Synthetic construct Homo sapiens clone ccsbBroadEn_02184 TECR gene, encodes complete protein.LF373196 - JP 2014500723-A/180699: Polycomb-Associated Non-Coding RNAs.LF373195 - JP 2014500723-A/180698: Polycomb-Associated Non-Coding RNAs.LF373194 - JP 2014500723-A/180697: Polycomb-Associated Non-Coding RNAs.LF373193 - JP 2014500723-A/180696: Polycomb-Associated Non-Coding RNAs.JD270591 - Sequence 251615 from Patent EP1572962.JD191404 - Sequence 172428 from Patent EP1572962.JD055348 - Sequence 36372 from Patent EP1572962.MA646228 - JP 2017113010-A/4152: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.MA730793 - JP 2017125065-A/580: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.MA734112 - JP 2017140048-A/2982: TERMINALLY MODIFIED RNA.MA619984 - JP 2018138019-A/191910: Polycomb-Associated Non-Coding RNAs.MA608779 - JP 2018138019-A/180705: Polycomb-Associated Non-Coding RNAs.MA608773 - JP 2018138019-A/180699: Polycomb-Associated Non-Coding RNAs.MA608772 - JP 2018138019-A/180698: Polycomb-Associated Non-Coding RNAs.MA608771 - JP 2018138019-A/180697: Polycomb-Associated Non-Coding RNAs.MA608770 - JP 2018138019-A/180696: Polycomb-Associated Non-Coding RNAs.MP045536 - Sequence 358 from Patent EP3401394.MP084206 - Sequence 358 from Patent EP3401393.MP045424 - Sequence 246 from Patent EP3401394.MP084094 - Sequence 246 from Patent EP3401393.MA803281 - JP 2018183181-A/4152: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.MB446372 - JP 2018143248-A/5: Method for measuring miRNA, and therapeutic agent for cancer and pharmaceutical composition for cancer therapy containing the same.
Biochemical and Signaling Pathways
Other Names for This Gene
Alternate Gene Symbols: B2RD55, ENST00000215567.1, ENST00000215567.2, ENST00000215567.3, ENST00000215567.4, ENST00000215567.5, ENST00000215567.6, ENST00000215567.7, ENST00000215567.8, ENST00000215567.9, GPSN2, NM_138501, O75350, Q6IBB2, Q9BWK3, Q9NZ01, Q9Y6P0, SC2, TECR_HUMAN, uc317cmd.1, uc317cmd.2UCSC ID: ENST00000215567.10_4RefSeq Accession: NM_138501.6
Protein: Q9NZ01
(aka TECR_HUMAN)
Gene Model Information
Click here
for a detailed description of the fields of the table above.
Methods, Credits, and Use Restrictions
Click here
for details on how this gene model was made and data restrictions if any.